This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (5) Citing Articles via Google Scholar Google Scholar Articles by Saccardi, R Search for Related Content PubMed PubMed Citation Articles by Saccardi, R Social Bookmarking                   What's this?

Autologous stem cell transplantation for progressive multiple sclerosis: Update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database

BMT Unit Department of Hematology, Ospedale di Careggi, Florence, Italy

T Kozak

Department of Clinical Hematology, Third Medical School, Charles University, Prague 10, Czech Republic

C Bocelli-Tyndall

Department of Rheumatology, University Hospital, Basel, Switzerland

A Fassas

Hematology Department/BMT Unit, George Papanicolaou General Hospital, Thessaloniki, Greece

A Kazis

Department of Neurology, George Papanicolaou General Hospital, Thessaloniki, Greece

E Havrdova

Department of Neurology, First Medical School, Charles University, Prague 2, Czech Republic

E Carreras

Department of Hematology, Hospital Clinic, Institute of Hematology and Oncology, Barcelona, Spain

A Saiz

Laboratory of Experimental Neurology and Immunology, Hospital Clinic, Barcelona, Spain

B Löwenberg

Erasmus University Medical Center, Rotterdam, The Netherlands

P AW te Boekhorst

Erasmus University Medical Center, Rotterdam, The Netherlands

F Gualandi

Department of Hematology, San Martino Hospital, Genova, Italy

H Openshaw

City of Hope National Medical Center, Duarte, CA, USA

G Longo

BMT Unit Department of Hematology, Ospedale di Careggi, Florence, Italy

F Pagliai

BMT Unit Department of Hematology, Ospedale di Careggi, Florence, Italy

L Massacesi

Department of Neurology, Ospedale di Careggi, Florence, Italy

E Deconink

Service d’Hématologie, Hopital Jean Minjoz, Besançon, France

J Ouyang

Department of Hematology, Drum Tower Hospital, Nanjing, PR China

F JZ Nagore

Hospital Vall d’Hebron, Barcelona, Spain

J Besalduch

Hematology Service, Hospital Universitari Son Dureta, Palma de Mallorca, Spain

I A Lisukov

Institute of Clinical Immunology, Novosibirsk, Russia

A Bonini

Hematology Unit, Azienda Ospedaliera ASMN, Reggio Emilia, Italy

E Merelli

Clinica Neurologica, Azienda Ospedaliera Policlinico, Modena, Italy

S Slavin

Department of Bone Marrow Transplantation, Hadassah University Hospital, Jerusalem, Israel

A Gratwohl

Department of Hematology, University Hospital, Basel, Switzerland

J Passweg

Department of Hematology, University Hospital, Basel, Switzerland

A Tyndall

Department of Rheumatology, University Hospital, Basel, Switzerland

A J Steck

Department of Neurology, University Hospital, Basel, Switzerland

M Andolina

Istituto per l’Infanzia Burlo Garofolo, Trieste, Italy

M Capobianco

Ospedale di San Luigi Gonzaga, Orbassano, Torino, Italy

J LD Martin

Sección de Trasplante de Medula Osea, Hospital Gregorio Marañón, Madrid, Spain

A Lugaresi

Università Gabriele d’Annunzio, Chieti, Italy

G Meucci

Department of Neuroscience, University Hospital of Pisa, Neurology Clinic, Pisa, Italy

R A Sáez

Department of Hematology, Hospital de la Princesa, Madrid, Spain

R E Clark

Department of Haematology, Royal Liverpool University Hospital, Liverpool, UK

M N Fernandez

Clinica Puerta de Hierro, Servicio de Hematologia y Hemoterapia, Madrid, Spain

L Fouillard

Department of Hematology, Hopital Saint Antoine, Paris, France

B Herstenstein

Department of Hematology/Oncology, Hannover Medical University, Hannover, Germany

V Koza

Department of Hematology/Oncology, Charles University Hospital, Pilsen, Czech Republic

E Cocco

‘R Binaghi Hospital’, Centro Sclerosi Multipla, Cagliari, Italy

H Baurmann

Neurologie und Klinische Neurophysiologie, Wiesbaden, Germany

G L Mancardi

Department of Neuroscience, Ophthalmology and Genetics, San Martino Hospital, University of Genova, Genova, Italy

Autoimmune Diseases Working Party of EBMT

Over the last decade, hematopoietic stem cells transplantation (HSCT) has been increasingly used in the treatment of severe progressive autoimmune diseases. We report a retrospective survey of 183 multiple sclerosis (MS) patients, recorded in the database of the European Blood and Marrow Transplantation Group (EBMT). Transplant data were available from 178 patients who received an autologous graft. Overall, transplant related mortality (TRM) was 5.3% and was restricted to the period 1995-2000, with no further TRM reported since then. Busulphan-based regimens were significantly associated with TRM. Clinical status at the time of transplant and transplant techniques showed some correlations with toxicity. No toxic deaths were reported among the 53 patients treated with the BEAM (carmustine, etoposide, cytosine-arabinoside, melphalan)/antithymocyte globulin (ATG) regimen without graft manipulation, irrespective of their clinical condition at the time of the transplant. Improvement or stabilization of neurological conditions occurred in 63% of patients at a median follow-up of 41.7 months, and was not associated with the intensity of the conditioning regimen. In this large series, HSCT was shown as a promising procedure to slow down progression in a subset of patients affected by severe, progressive MS; the safety and feasibility of the procedure can be significantly improved by appropriate patient selection and choice of transplant regimen.

Key Words: autoimmune diseases • immunosuppression • multiple sclerosis • stem cells transplantation • treatment safety

References

• Hough RE, Snowden JA, Wulffraat NM. Haemopoietic stem cell transplantation in autoimmune diseases: a European perspective . Br J Haematol 2005; 128: 432-459 .[CrossRef][ISI][Medline] [Order article via Infotrieve]
• Marmont AM. Stem cell transplantation for severe autoimmune disorders, with special reference to rheumatic diseases . J Rheumatol Suppl 1997; 48: 13-18 .[Medline] [Order article via Infotrieve]
• Tyndall A, Fassas A, Passweg J, Ruiz de Elvira C, Attal M, Brooks Pet al. Autologous haematopoietic stem cell transplants for autoimmune disease-feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Against Rheumatism and the International Stem Cell Project for Autoimmune Disease . Bone Marrow Transplant 1999; 24: 729-734 .[CrossRef][ISI][Medline] [Order article via Infotrieve]
• Tyndall A, Saccardi R. Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from phase I/II studies, prospective randomized trials and future directions . Clin Exp Immunol 2005; 141: 1-9 .[CrossRef][ISI][Medline] [Order article via Infotrieve]
• Burt RK, Fassas A, Snowden J, van Laar JM, Kozak T, Wulffraat NMet al. Collection of hematopoietic stem cells from patients with autoimmune diseases . Bone Marrow Transplant 2001; 28: 1-12 .[CrossRef][ISI][Medline] [Order article via Infotrieve]
• Muraro PA, Douek DC, Packer A, Chung K, Guenaga FJ, Cassiani-Ingoni Ret al. Thymic output generates a new and diverse TCR repertoire after auto-logous stem cell transplantation in multiple sclerosis patients . J Exp Med 2005; 201: 805-816 .[Abstract/Free Full Text]
• Sykes M, Nikolic B. Treatment of severe autoimmune disease by stem-cell transplantation . Nature 2005; 435: 620-627 .[CrossRef][Medline] [Order article via Infotrieve]
• Edan G, Morrissey S, Le Page E. Rationale for the use of mitoxantrone in multiple sclerosis . J Neurol Sci 2004; 223: 35-39 .[CrossRef][ISI][Medline] [Order article via Infotrieve]
• Hartung HP, Gonsette R, Konig N, Kwiecinski H, Guseo A, Morrissey SPet al. Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial . Lancet 2002; 360: 2018-2025 .[CrossRef][ISI][Medline] [Order article via Infotrieve]
• Saccardi R, Tyndall A, Coghlan G, Denton C, Edan G, Emdin Met al. Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis . Bone Marrow Transplant 2004; 34: 877-881 .[CrossRef][Medline] [Order article via Infotrieve]
• Fassas A, Anagnostopoulos A, Kazis A, Kapinas K, Sakellari I, Kimiskidis Vet al. Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study . Bone Marrow Transplant 1997; 20: 631-638 .[CrossRef][ISI][Medline] [Order article via Infotrieve]
• Burt RK, Traynor AE, Cohen B, Karlin KH, Davis FA, Stefoski Det al. T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patients . Bone Marrow Transplant 1998; 21: 537-541 .[CrossRef][ISI][Medline] [Order article via Infotrieve]
• Kozak T, Havrdova E, Pit’ha J, Gregora E, Pytlik R, Maaloufova Jet al. High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis . Bone Marrow Transplant 2000; 25: 525-531 .[CrossRef][ISI][Medline] [Order article via Infotrieve]
• Openshaw H, Lund BT, Kashyap A, Atkinson R, Sniecinski I, Weiner LPet al. Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: report of toxicity and immunological monitoring . Biol Blood Marrow Transplant 2000; 6: 563-575 .[CrossRef][ISI][Medline] [Order article via Infotrieve]
• Mancardi GL, Saccardi R, Filippi M, Gualandi F, Murialdo A, Inglese Met al. Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS . Neurology 2001; 57: 62-68 .[Abstract/Free Full Text]
• Nash RA, Bowen JD, McSweeney PA, Pavletic SZ, Maravilla KR, Park MSet al. High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis . Blood 2003; 102: 2364-2372 .[Abstract/Free Full Text]
• Saiz A, Blanco Y, Carreras E, Berenguer J, Rovira M, Pujol Tet al. Clinical and MRI outcome after autologous hematopoietic stem cell transplantation in MS . Neurology 2004; 62: 282-284 .[Abstract/Free Full Text]
• Saccardi R, Mancardi GL, Solari A, Bosi A, Bruzzi P, Di Bartolomeo Pet al. Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life . Blood 2005; 105: 2601-2607 .[Medline] [Order article via Infotrieve]
• Tyndall A, Gratwohl A. Blood and marrow stem cell transplants in autoimmune disease. A consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT) . Br J Rheumatol 1997; 36: 390-392 .[Free Full Text]
• Fassas A, Passweg JR, Anagnostopoulos A, Kazis A, Kozak T, Havrdova Eet al. Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study . J Neurol 2002; 249: 1088-1097 .[CrossRef][ISI][Medline] [Order article via Infotrieve]
• Burt RK, Cohen BA, Russell E, Spero K, Joshi A, Oyama Yet al. Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation-based conditioning regimen to prevent disease progression in patients with high disability scores . Blood 2003; 102: 2373-2378 .[Abstract/Free Full Text]
• Carreras E, Saiz A, Marin P, Martinez C, Rovira M, Villamor Net al. CD34+/selected autologous peripheral blood stem cell transplantation for multiple sclerosis: report of toxicity and treatment results at one year of follow-up in 15 patients . Haematologica 2003; 88: 306-314 .[Abstract/Free Full Text]
• Fassas A, Anagnostopoulos A, Kazis A, Kapinas K, Sakellari I, Kimiskidis Vet al. Autologous stem cell transplantation in progressive multiple sclerosis-an interim analysis of efficacy . J Clin Immunol 2000; 20: 24-30 .[CrossRef][ISI][Medline] [Order article via Infotrieve]
• Blanco Y, Saiz A, Carreras E, Graus F. Autologous haematopoietic-stem-cell transplantation for multiple sclerosis . Lancet Neurol 2005; 4: 54-63 .[CrossRef][ISI][Medline] [Order article via Infotrieve]
• Frassoni F, Labopin M, Powles R, Mary JY, Arcese W, Bacigalupo Aet al. Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation . Lancet 2000; 355: 1393-1398 .[CrossRef][ISI][Medline] [Order article via Infotrieve]
• Griffith LM, Pavletic SZ, Tyndall A, Bredeson CN, Bowen JD, Childs RWet al. Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a national institute of allergy and infectious diseases and national cancer institute-sponsored international workshop, Bethesda, MD, March 12 and 13, 2005 . Biol Blood Marrow Transplant 2005; 11: 862-870 .[CrossRef][ISI][Medline] [Order article via Infotrieve]
• Gratwohl A, Passweg J, Bocelli-Tyndall C, Fassas A, van Laar JM, Farge Det al. Autologous hematopoietic stem cell transplantation for autoimmune diseases . Bone Marrow Transplant 2005; 35: 869-879 .[CrossRef][ISI][Medline] [Order article via Infotrieve]
• Mancardi GL, Murialdo A, Rossi P, Gualandi F, Martino G, Marmont Aet al. Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis . Mult Scler 2005; 11: 367-371 .[Abstract/Free Full Text]
• Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis . N Engl J Med 1998; 338: 278-285 .[Abstract/Free Full Text]

CiteULike

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				V. Kimiskidis, I. Sakellari, V. Tsimourtou, V. Kapina, S. Papagiannopoulos, D. Kazis, N. Vlaikidis, A. Anagnostopoulos, and A. Fassas Autologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcome Multiple Sclerosis, March 1, 2008; 14(2): 278 - 283. [Abstract] [PDF]

				R. K. Burt, Y. Loh, W. Pearce, N. Beohar, W. G. Barr, R. Craig, Y. Wen, J. A. Rapp, and J. Kessler Clinical Applications of Blood-Derived and Marrow-Derived Stem Cells for Nonmalignant Diseases JAMA, February 27, 2008; 299(8): 925 - 936. [Abstract] [Full Text] [PDF]

				A Cassinotti, C Annaloro, S Ardizzone, F Onida, A D. Volpe, M Clerici, P Usardi, S Greco, G Maconi, G B. Porro, et al. Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease Gut, February 1, 2008; 57(2): 211 - 217. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (5) Citing Articles via Google Scholar Google Scholar Articles by Saccardi, R Search for Related Content PubMed PubMed Citation Articles by Saccardi, R Social Bookmarking                   What's this?